Isosorbide Mononitrate/Cilostazol for Lacunar Cerebral Small Vessel Disease-Outcomes at 6 Months in the LACI-2 Randomized Controlled Trial.

Bath PM, Woodhouse LJ, Mhlanga I, Bamford J, Cvoro V, Doubal FN, England TJ, Hassan A, Montgomery AA, O'Brien JT, Roffe C, Sprigg N, Werring DJ, Wardlaw JM, LACI‐2 Trial Investigators

Open source

DOI: 10.1161/jaha.125.046235
Published: 2026 Aug 4
Container: Journal of the American Heart Association
Publisher: Not recorded
Open access: no

Credibility signals

uncertain Score 51/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1161/jaha.125.046235,
  title = {Isosorbide Mononitrate/Cilostazol for Lacunar Cerebral Small Vessel Disease-Outcomes at 6 Months in the LACI-2 Randomized Controlled Trial.},
  author = {Bath PM and Woodhouse LJ and Mhlanga I and Bamford J and Cvoro V and Doubal FN and England TJ and Hassan A and Montgomery AA and O'Brien JT and Roffe C and Sprigg N and Werring DJ and Wardlaw JM and LACI‐2 Trial Investigators},
  year = {2026},
  journal = {Journal of the American Heart Association},
  doi = {10.1161/jaha.125.046235},
  url = {https://doi.org/10.1161/jaha.125.046235}
}

RIS

TY  - JOUR
TI  - Isosorbide Mononitrate/Cilostazol for Lacunar Cerebral Small Vessel Disease-Outcomes at 6 Months in the LACI-2 Randomized Controlled Trial.
AU  - Bath PM
AU  - Woodhouse LJ
AU  - Mhlanga I
AU  - Bamford J
AU  - Cvoro V
AU  - Doubal FN
AU  - England TJ
AU  - Hassan A
AU  - Montgomery AA
AU  - O'Brien JT
AU  - Roffe C
AU  - Sprigg N
AU  - Werring DJ
AU  - Wardlaw JM
AU  - LACI‐2 Trial Investigators
PY  - 2026
JO  - Journal of the American Heart Association
DO  - 10.1161/jaha.125.046235
UR  - https://doi.org/10.1161/jaha.125.046235
ER  -

APA

PM, B., LJ, W., I, M., J, B., V, C., FN, D., TJ, E., A, H., AA, M., JT, O., C, R., N, S., DJ, W., JM, W., & Investigators, L. T. (2026). Isosorbide Mononitrate/Cilostazol for Lacunar Cerebral Small Vessel Disease-Outcomes at 6 Months in the LACI-2 Randomized Controlled Trial.. Journal of the American Heart Association. https://doi.org/10.1161/jaha.125.046235

Source records

pubmed · retrieved 2026-09-26T11:05:53.403Z
europe-pmc · retrieved 2026-09-26T11:05:53.419Z
doaj · retrieved 2026-09-26T11:05:53.403Z